Page last updated: 2024-11-01

nomifensine and HIV Coinfection

nomifensine has been researched along with HIV Coinfection in 1 studies

Nomifensine: An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266)
nomifensine : An N-methylated tetrahydroisoquinoline carrying phenyl and amino substituents at positions C-4 and C-8, respectively.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Davis, SE3
Ferris, MJ3
Ananthan, S3
Augelli-Szafran, CE3
Zhu, J3

Other Studies

1 other study available for nomifensine and HIV Coinfection

ArticleYear
Novel Allosteric Modulator Southern Research Institute-32743 Reverses HIV-1 Transactivator of Transcription-Induced Increase in Dopamine Release in the Caudate Putamen of Inducible Transactivator of Transcription Transgenic Mice.
    The Journal of pharmacology and experimental therapeutics, 2023, Volume: 384, Issue:2

    Topics: Animals; Dopamine; Dopamine Plasma Membrane Transport Proteins; HIV Infections; HIV-1; Humans; Mice;

2023
Novel Allosteric Modulator Southern Research Institute-32743 Reverses HIV-1 Transactivator of Transcription-Induced Increase in Dopamine Release in the Caudate Putamen of Inducible Transactivator of Transcription Transgenic Mice.
    The Journal of pharmacology and experimental therapeutics, 2023, Volume: 384, Issue:2

    Topics: Animals; Dopamine; Dopamine Plasma Membrane Transport Proteins; HIV Infections; HIV-1; Humans; Mice;

2023
Novel Allosteric Modulator Southern Research Institute-32743 Reverses HIV-1 Transactivator of Transcription-Induced Increase in Dopamine Release in the Caudate Putamen of Inducible Transactivator of Transcription Transgenic Mice.
    The Journal of pharmacology and experimental therapeutics, 2023, Volume: 384, Issue:2

    Topics: Animals; Dopamine; Dopamine Plasma Membrane Transport Proteins; HIV Infections; HIV-1; Humans; Mice;

2023
Novel Allosteric Modulator Southern Research Institute-32743 Reverses HIV-1 Transactivator of Transcription-Induced Increase in Dopamine Release in the Caudate Putamen of Inducible Transactivator of Transcription Transgenic Mice.
    The Journal of pharmacology and experimental therapeutics, 2023, Volume: 384, Issue:2

    Topics: Animals; Dopamine; Dopamine Plasma Membrane Transport Proteins; HIV Infections; HIV-1; Humans; Mice;

2023